158 related articles for article (PubMed ID: 33622576)
21. Ewing's sarcoma of bone. Experience with 140 patients.
Wilkins RM; Pritchard DJ; Burgert EO; Unni KK
Cancer; 1986 Dec; 58(11):2551-5. PubMed ID: 3768846
[TBL] [Abstract][Full Text] [Related]
22. Treatment outcomes of Japanese patients with Ewing sarcoma: differences between skeletal and extraskeletal Ewing sarcoma.
Takenaka S; Naka N; Obata H; Joyama S; Hamada K; Imura Y; Kakunaga S; Aoki Y; Ueda T; Araki N; Yoshikawa H
Jpn J Clin Oncol; 2016 Jun; 46(6):522-8. PubMed ID: 27008849
[TBL] [Abstract][Full Text] [Related]
23. [Ewing sarcoma of the bone. Multidisciplinary approach and oncological results in 88 patients].
Sanchez-Saba JE; Abrego MO; Albergo JI; Farfalli GL; Aponte-Tinao LA; Ayerza MA; Cayol F; Streitenberger P; Risk MR; Roitman PD
Medicina (B Aires); 2020; 80(1):23-30. PubMed ID: 32044738
[TBL] [Abstract][Full Text] [Related]
24. Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86.
Paulussen M; Ahrens S; Dunst J; Winkelmann W; Exner GU; Kotz R; Amann G; Dockhorn-Dworniczak B; Harms D; Müller-Weihrich S; Welte K; Kornhuber B; Janka-Schaub G; Göbel U; Treuner J; Voûte PA; Zoubek A; Gadner H; Jürgens H
J Clin Oncol; 2001 Mar; 19(6):1818-29. PubMed ID: 11251014
[TBL] [Abstract][Full Text] [Related]
25. Extended Neoadjuvant Chemotherapy in Delayed Primary Resection of Ewing Sarcoma During the COVID-19 Era: A Case Report.
Arunwatthanangkul P; Rangchaikul N; Anuwongworavet S; Chobpenthai T
JBJS Case Connect; 2023 Apr; 13(2):. PubMed ID: 37053359
[TBL] [Abstract][Full Text] [Related]
26. [Efficacy and survival of 92 cases of Ewing's sarcoma family of tumor initially treated with multidisciplinary therapy].
Peng RJ; Sun XF; Xiang XJ; Zhen ZJ; Ling JY; Tong GL; Xia Y; Xu GC; Jiang WQ
Ai Zheng; 2009 Dec; 28(12):1304-9. PubMed ID: 19958626
[TBL] [Abstract][Full Text] [Related]
27. Nonmetastatic pelvic Ewing sarcoma: report of the French society of pediatric oncology.
Carrie C; Mascard E; Gomez F; Habrand JL; Alapetite C; Oberlin O; Moncho V; Hoffstetter S
Med Pediatr Oncol; 1999 Nov; 33(5):444-9. PubMed ID: 10531567
[TBL] [Abstract][Full Text] [Related]
28. Outcomes with nondose-dense chemotherapy for Ewing sarcoma: A practical approach for the developing world.
Parambil BC; Vora T; Sankaran H; Prasad M; Bakshi A; Puri A; Gulia A; Qureshi S; Laskar S; Khanna N; Shah S; Ramadwar M; Kembhavi S; Chinnaswamy G; Banavali S
Pediatr Blood Cancer; 2020 Nov; 67(11):e28604. PubMed ID: 32706522
[TBL] [Abstract][Full Text] [Related]
29. Risk analysis factors for local recurrence in Ewing's sarcoma: when should adjuvant radiotherapy be administered?
Albergo JI; Gaston CLL; Parry MC; Laitinen MK; Jeys LM; Tillman RM; Abudu AT; Grimer RJ
Bone Joint J; 2018 Feb; 100-B(2):247-255. PubMed ID: 29437069
[TBL] [Abstract][Full Text] [Related]
30. Non-metastatic Ewing's sarcoma family of tumors of bone in adolescents and adults: prognostic factors and clinical outcome-single institution results.
Oksüz DC; Tural D; Dincbas FÖ; Dervisoglu S; Turna H; Hiz M; Kantarci F; Ceylaner B; Koca S; Mandel NM
Tumori; 2014; 100(4):452-8. PubMed ID: 25296596
[TBL] [Abstract][Full Text] [Related]
31. Therapy and survival after recurrence of Ewing's tumors: the Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997.
Bacci G; Ferrari S; Longhi A; Donati D; De Paolis M; Forni C; Versari M; Setola E; Briccoli A; Barbieri E
Ann Oncol; 2003 Nov; 14(11):1654-9. PubMed ID: 14581274
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors in Ewing's sarcoma of the foot.
Casadei R; Magnani M; Biagini R; Mercuri M
Clin Orthop Relat Res; 2004 Mar; (420):230-8. PubMed ID: 15057103
[TBL] [Abstract][Full Text] [Related]
33. Tumour volume as a predictor of necrosis after chemotherapy in Ewing's sarcoma.
Abudu A; Davies AM; Pynsent PB; Mangham DC; Tillman RM; Carter SR; Grimer RJ
J Bone Joint Surg Br; 1999 Mar; 81(2):317-22. PubMed ID: 10204943
[TBL] [Abstract][Full Text] [Related]
34. Radiation Treatment for Ewing Sarcoma Family of Tumors in Adult Patients: A Single Institution's Experience Over 40 Years.
Kharod SM; Spiguel AR; Lagmay JP; Jones C; Morris CG; Gibbs CP; Zlotecki RA
Am J Clin Oncol; 2019 May; 42(5):421-425. PubMed ID: 30883389
[TBL] [Abstract][Full Text] [Related]
35. Complete tumor necrosis after neoadjuvant chemotherapy defines good responders in patients with Ewing sarcoma.
Lozano-Calderón SA; Albergo JI; Groot OQ; Merchan NA; El Abiad JM; Salinas V; Gomez Mier LC; Montoya CS; Ferrone ML; Ready JE; Linares FJ; Levin AS; Peleteiro Pensado M; Pozo Kreilinger JJ; Ruiz IB; Ortiz-Cruz EJ; Gebhardt MC; Cote GM; Choy E; Spentzos D; Hung YP; Deshpande V; Chebib IA; McCulloch RA; Farfalli G; Aponte Tinao L; Morris CD; Petur Nielsen G; Anderson ME; Jeys LM
Cancer; 2023 Jan; 129(1):60-70. PubMed ID: 36305090
[TBL] [Abstract][Full Text] [Related]
36. Primary cutaneous and subcutaneous Ewing sarcoma.
Di Giannatale A; Frezza AM; Le Deley MC; Marec-Bérard P; Benson C; Blay JY; Bui B; Judson I; Oberlin O; Whelan J; Gaspar N
Pediatr Blood Cancer; 2015 Sep; 62(9):1555-61. PubMed ID: 25894676
[TBL] [Abstract][Full Text] [Related]
37. The role of radiotherapy in local control of nonextremity Ewing sarcomas.
Akagunduz OO; Kamer SA; Kececi B; Demirag B; Oniz H; Kantar M; Cetingul N; Sabah D; Anacak Y
Tumori; 2016; 102(2):162-7. PubMed ID: 26917407
[TBL] [Abstract][Full Text] [Related]
38. Response to chemotherapy estimates by FDG PET is an important prognostic factor in patients with Ewing sarcoma.
Raciborska A; Bilska K; Drabko K; Michalak E; Chaber R; Pogorzała M; Połczyńska K; Sobol G; Wieczorek M; Muszyńska-Rosłan K; Rychlowska-Pruszyńska M; Rodriguez-Galindo C; Dziuk M
Clin Transl Oncol; 2016 Feb; 18(2):189-95. PubMed ID: 26250765
[TBL] [Abstract][Full Text] [Related]
39. Long-lasting multiagent chemotherapy in adult high-risk Ewing's sarcoma of bone.
Ataergin S; Ozet A; Solchaga L; Turan M; Beyzadeoglu M; Oysul K; Arpaci F; Komurcu S; Surenkok S; Ozturk M
Med Oncol; 2009; 26(3):276-86. PubMed ID: 18989798
[TBL] [Abstract][Full Text] [Related]
40. Primary chest wall sarcoma; a single institution experience of 3 years.
Gangopadhyay A; Nandy K; Puj K; Sharma M; Jayaprakash D; Salunke A; Jain A; Pandya S
Cancer Treat Res Commun; 2021; 27():100326. PubMed ID: 33524850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
